Institutional investors purchased a net $203.8 thousand shares of CPHD during the quarter ended December 2015 and now own 107.48% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CHAMPLAIN INVESTMENT PARTNERS LL... Bought 1.6 Million shares of Cepheid
FIRST TRUST ADVISORS LP Bought 1.0 Million shares of Cepheid
WELLINGTON MANAGEMENT CO. LLP Bought 993.5 Thousand shares of Cepheid